pharmalot (@pharmalot) header
pharmalot (@pharmalot) profile picture

pharmalot

@pharmalot

The latest news and views about the pharmaceutical industry, with @EdSilverman of @Statnews, ex-WSJ.. tips: [email protected]

 New Jersey & New York
statnews.com/pharmalot/
Joined February 2008
  • Tweets17.8K
  • Following1.3K
  • Followers58.4K
4Media
Photo by pharmalot (@pharmalot)Photo by pharmalot (@pharmalot)Photo by pharmalot (@pharmalot)Photo by pharmalot (@pharmalot)
Up and Down the Ladder: Job Changes.. the latest comings and goings.. statnews.com/pharmalot/2026/… #pharma #biotech #jobs #EliLilly #Lilly $LLY
Up and down the ladder: The latest comings and goings

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

statnews.com
2
310
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more news.. statnews.com/pharmalot/2026/… #pharma #AstraZeneca #SunPharma #PBM #antimicrobials #EMA #Lundbeck
Pharmalittle: We're reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more

Pharmalittle: We're reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more

AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D

statnews.com
1
429
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more news.. statnews.com/pharmalot/2026/… #pharma #peptides #China #biotech #PBM #Trump #insulin #patent #Sanofi $SNY $ARTV
Pharmalittle: We're reading about a new policy for compounding peptides, a PBM disclosure rule, and...

Pharmalittle: We're reading about a new policy for compounding peptides, a PBM disclosure rule, and...

HHS released a policy that will temporarily allow compounding pharmacies to manufacture some peptide products

statnews.com
1
478
Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings.. statnews.com/pharmalot/2026/… #pharma #medicines #Trump #transparency #GAO #MFN
Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings

Lawmaker wants government watchdog to probe TrumpRx over claims about drug savings

A House lawmaker asked the Government Accountability Office to review whether the TrumpRx platform has saved Americans any money.

statnews.com
1
3
725
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about 340B battles, new results for a Lilly weight loss drug, and more news.. statnews.com/pharmalot/2026/… #pharma #weight #obesity #diabetes #340B #PBM #FDA #hospital #Amgen #Lilly $AMGN $LLY
Pharmalittle: We're reading about 340B battles, new results for a Lilly weight loss drug, and more

Pharmalittle: We're reading about 340B battles, new results for a Lilly weight loss drug, and more

Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B program

statnews.com
525
Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts... statnews.com/pharmalot/2026/… #pharma #340B #hospitals #medicines #Missouri #Lilly $LLY $NVO

Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.

statnews.com
2
4
1,090
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a Novo setback in court, a House probe into big PBMs, and more news.. statnews.com/pharmalot/2026/… #pharma #PBM #weight #obesity #cancer #GSK #NovoNordisk #Lilly #Incyte #CVS $ARTV $CVS $LLY $NVO $GSK $INCY $CI $UNH
Pharmalittle: We're reading about a Novo setback in court, a House probe into big PBMs, and more

Pharmalittle: We're reading about a Novo setback in court, a House probe into big PBMs, and more

A U.S. judge rejected a bid to block ‌Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs

statnews.com
1
533
House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies.. statnews.com/pharmalot/2026/… #pharma #pharmacy #PBM #medicines #CVS #Cigna #UnitedHealth #FTC $CVS $UNH $CI
House lawmaker probes PBMs for 'punitive' audits of independent pharmacies

House lawmaker probes PBMs for 'punitive' audits of independent pharmacies

A House lawmaker is investigating whether the three largest PMS targeted independent pharmacies withretaliatory audits.

statnews.com
706
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more news.. statnews.com/pharmalot/2026/… #pharma #biotech #cancer #Roche #AstraZeneca #Lilly #Regeneron #BristolMyers $RHHBY $LLY $BMY $REGN $AZN
Pharmalittle: We're reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more

Pharmalittle: We're reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more

Bristol Myers Squibb reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial

statnews.com
1
2
629
Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds... statnews.com/pharmalot/2026/… #pharma #biotech #cancer #Europe #China #clinicaltrials #oncology #ESMO26
Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds

Most cancer drugs approved by European regulators lack a high clinical benefit, analysis finds

Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, a new analysis finds.

statnews.com
2
2
607
Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? statnews.com/pharmalot/2026/… #pharma #biotech #jobs #Novartis #GSK
Up and down the ladder: The latest comings and goings

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

statnews.com
1
729
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a cancer vaccine, an experimental pancreatic cancer drug, and more news.. statnews.com/pharmalot/2026/… #pharma #cancer #vaccine #China #biotech #weight #Ozempic #kickbacks #340B $MRK $MRNA $ALNY $RVMD $BAX $TNGX
Pharmalittle: We're reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

Pharmalittle: We're reading about a cancer vaccine, an experimental pancreatic cancer drug, and more

A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment

statnews.com
1
552
Gilead to pay $45 million to settle kickback charges filed by Texas attorney general.. statnews.com/pharmalot/2026/… #pharma #medicines #kickback #Texas #Medicaid #Gilead $GILD
Gilead to pay $45 million to settle kickback charges filed by Texas attorney general

Gilead to pay $45 million to settle kickback charges filed by Texas attorney general

Gilead Sciences agreed to pay $45 million to settle allegations of paying kickbacks that improperly influenced prescriptions paid for by the Texas Medicaid program

statnews.com
1
738
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage, and more news.. statnews.com/pharmalot/2026/… #pharma #telehealth #addiction #China #biotech #Belgium #obesity #Roche #Lilly #UK #ClinicalTrials #Roivant
Pharmalittle: We're reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage,...

Pharmalittle: We're reading about a U.S. rule on Chinese deals, Belgium refusing Mounjaro coverage,...

U.S. is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to additional scrutiny

statnews.com
5
1
1
630
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and more news.. statnews.com/pharmalot/2026/… #pharma #MarkCuban #medicines #ketamine #weight #obesity #shortages #antibiotics #penicillin #China
Pharmalittle: We're reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and...

Pharmalittle: We're reading about Mark Cuban eyeing rare disease drugs, a ketamine gold rush, and...

Mark Cuban has a new vision for his company Cost Plus Drugs: shake up the business of custom-made rare disease medicines

statnews.com
553
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about drug launch prices, an AstraZeneca AI deal, and more news.. statnews.com/pharmalot/2026/… #pharma #AI #medicines #value #AstraZeneca #India #weight #obesity #Novo #compounding #pharmacy #GSK #cancer $GSK $NVO $AZN
Pharmalittle: We're reading about drug launch prices, an AstraZeneca AI deal, and more

Pharmalittle: We're reading about drug launch prices, an AstraZeneca AI deal, and more

The median net price for newly launched medicines, when adjusted for inflation and manufacturer discounts, rose by 35% from 2022 to 2025.

statnews.com
1
605
Launch prices for new medicines dipped slightly last year but remain high, analysis finds.. statnews.com/pharmalot/2026/… #pharma #medicines #HealthInsurance #value #
Launch prices for new medicines dipped slightly last year but remain high, analysis finds

Launch prices for new medicines dipped slightly last year but remain high, analysis finds

The median net price for 202 newly launched medicines rose by 35%, to $257,000 last year from $173,000 in 2022.

statnews.com
1
718
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more news.. statnews.com/pharmalot/2026/… #pharma #Germany #Gilead #Belgium #Roche #Merck #FDA #Novartis #Novavax $GILD $RHHBY $NVS $NVAX $MKKGY
Pharmalittle: We're reading about Roche investments in Germany, a Gilead bowel disease drug, and...

Pharmalittle: We're reading about Roche investments in Germany, a Gilead bowel disease drug, and...

Roche is reviewing all future investments in Germany over health care cost-cutting ​policies, with a top executive citing a loss of trust

statnews.com
1
796
Up and Down the Ladder: Job Changes.. the latest comings & goings.. recognize anyone? statnews.com/pharmalot/2026/… #pharma #biotech #jobs #Gilead #Sanofi $GILD $SNY $BLCO
Up and down the ladder: The latest comings and goings

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

statnews.com
1
820
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more news.. statnews.com/pharmalot/2026/… #pharma #Trump #peptides #obesity #weight #Lilly #China #biotech #FDA #340B $LLY
Pharmalittle: We're reading about an HHS peptide push, Trump's pharma stock holdings, and more

Pharmalittle: We're reading about an HHS peptide push, Trump's pharma stock holdings, and more

The Trump administration is proceeding with a plan to allow compounding pharmacies to produce certain peptides

statnews.com
1
626
Load more